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Abstract
Purpose: The Victorian Institute of Sport Assessment-Patella (VISA-P) scale is the most condition-specific patient-reported outcome measure
used to assess symptom severity in athletes with patellar tendinopathy. Previous exploratory factor analyses have been conducted to evaluate the
scale’s dimensionality, with inconsistent results, and the factor structure of the scale remains unclear. The aims of the present study were to
determine the factorial structure of the VISA-P scale using confirmatory factor analysis (CFA) and test measurement invariance across sexes.
Methods: The study included a convenience sample of 249 Spanish athletes with patellar tendinopathy. CFA was performed to assess factorial
validity. Hypothesized 1- and 2-factor models were tested. Measurement invariance across sexes was evaluated via multi-group CFA with several
fit indices using EQS 6.1 software.
Results: The internal consistency coefficient was 0.74. Several CFA models were examined and the 1-factor model in which errors for items 7 and
8 were correlated showed acceptable fit in terms of comparative fit index (CFI) and goodness-of-fit index (GFI) statistics (CFI = 0.93; GFI = 0.94;
standardized root mean square residual = 0.06; root mean square error of approximation = 0.10; 90% confidence interval = 0.08–0.13). This model
was invariant across sexes.
Conclusion: The 1-factor model of the Spanish version of the VISA-P scale (VISA-P-Sp) in which errors for items 7 and 8 were correlated
demonstrated relative fit in CFA. Scores obtained via VISA-P-Sp can be compared between men and women without sex bias. Further studies
should examine the VISA-P scale and other single-score patient-reported outcome measures concurrently.
© 2016 Production and hosting by Elsevier B.V. on behalf of Shanghai University of Sport.
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1. Introduction
Patellar tendinopathy is a common overuse injury in sports,
particularly in jumping athletes.1 In addition to other means of
objective measurement, the use of patient-reported outcome
measures (PROMs) has become increasingly important in
assessing patients’ health status in recent years.2 For example,
structural changes in patellar tendinopathy can be studied using
ultrasound or magnetic resonance imaging, but image findings
and clinical symptoms are not always consistent.3 In order to
capture the patient experience, the use of PROMs in clinical
practice and research is highly recommended.4
The Victorian Institute of Sport Assessment-Patella
(VISA-P) scale is the only condition-specific scale for patellar
tendinopathy.5 It has become the most widely used PROM in
symptom severity assessment and the monitoring of changes
related to injury over time.6 Nowadays, several versions of the
VISA-P scale are available.7–14
The Consensus-based Standards for the Selection of Health
Measurement Instruments (COSMIN) initiative established a
set of standards, which are to be followed in studies assessing
the psychometric properties of health-related patient-reported
outcomes (PROs).15 One of these properties is the construct
validity, defined as “the degree to which a health-related PRO
instrument measures the construct(s) it purports to measure”.
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With respect to the validity of the VISA-P scale, the consen-
sus among experts is that it is a good measure of symptom
severity in patellar tendinopathy.6 The VISA-P scale can differ-
entiate scores from various well-known groups (e.g., healthy
individuals vs. those with tendinopathy) but is not a diagnostic
tool. It has been found to be strongly correlated with other
standardized instruments used to assess orthopedic knee disor-
ders (Lysholm and Modified Blazina scales), in addition to the
physical components of the Short Form-36 Health Survey; this
indicates good construct validity.11,12
However the factor structure of the VISA-P scale remains
unclear. Factor structure can contribute strongly to the assess-
ment of construct validity and is referred to as “the degree to
which the scores of a health-related PRO instrument are an
adequate reflection of the dimensionality of the construct to be
measured.”15 In health and sports medicine, PROs are often
measured indirectly through their manifestations, also called
“latent variables” or “constructs”.4
Since its original publication, the scale has generated a
single final score for patellar tendinopathy severity, measuring
this phenomenon quantified by the set of 8 items. There are no
subscales, suggesting a one-dimensional design and use for
this instrument. However, there was no technical information
regarding dimensionality provided in the original study.5 Con-
troversy surrounds the scale’s underlying factors and item
distribution by factor, due to the publication of various
cross-cultural adaptations using exploratory factorial analysis
(EFA).
Specifically, four cross-cultural adaptation studies have ana-
lyzed the factor structure of the VISA-P scale but their findings
were inconsistent.7,9,11,12 In all cases, a 2-factor solution was
drawn, allowing explanation of between 64.5% (Dutch) and
85.6% (Greek) of the variance. In Swedish and Dutch studies,
factor loadings for the item 1 (no pain while sitting) were
incongruent. Therefore, the authors forced a 3-factor solution,
accounting for 74.6% and 85% of the variance in the Dutch and
Swedish studies, respectively.
Factor descriptions and the assignment of items to factors
are also controversial issues: a Spanish study reported that
items 1–6 belong to the first factor (pain during activities), and
items 7 and 8 belong to the second (sport participation). The
distribution was very similar to that of the Dutch VISA-P scale
adaptation, with the exception of item 1, which was assigned to
an independent factor (pain while sitting). In the Swedish study,
there were two factors with single items: sit pain free (item 1)
and currently undertaking sports (item 7). The third factor
included the six remaining items. In their discussion of the
results, the Swedish authors suggested that item 1 may have
been an artifact and should be considered in the first factor. In
the Greek adaptation study, the first factor was pain/symptoms
during functional load and sports participation and included 6
items (2 and 4–8). A second identified factor, symptoms during
static loading, included items 1 and 3. However, they repeated
the analysis excluding the other knee injury group from the
analysis. In this case, only one factor, which explained 80.8% of
the total variance, was identified, and in a forced 2-factor solu-
tion, the second factor included item 7 alone.
To date, there is no consensus with respect to the number of
factors underlying the concept (or construct) of symptom sever-
ity in patellar tendinopathy, and assessment of VISA-P scale
factor structure is required.
These studies employed EFA (principal components with
varimax rotation), a statistical method that provides an initial,
or exploratory, indication as to whether the items of a PROM
are representative of single or multiple factors or constructs.
This EFA process requires a smaller sample and indicates the
direction for the more thorough confirmatory factor analysis
(CFA), a statistical process that uses assumptions, modeling,
and estimations to determine whether a questionnaire has a
multifaceted or single unitary structure.16
This variability in the results of the analysis of VISA-P scale
factor structure and the recommendations of the COSMIN ini-
tiative suggest that it is necessary to perform new analyses to
clarify this attribute of validity. Therefore, the aim of the
present study was to determine the factor structure of the
VISA-P scale using CFA. As a secondary consideration, and
due to the potential sex differences in pain perception and
tolerance reported in the literature,17,18 we assessed measure-
ment invariance in VISA-P scale scores across sexes using
multi-group confirmatory factor analysis (MGCFA).
2. Methods
2.1. Participants
A cross-sectional convenience sample was recruited.
Between January 2012 and October 2014, data were collected
from patients of 5 sports medicine clinics and members of 15
sports teams (volleyball, handball, and basketball) across
various geographic zones in Spain.
Consecutive athletes with patellar tendinopathy who had
undergone physiotherapy treatment were eligible if they were
aged at least 18 years; had a history of continuous pain for at
least 3 months or recurrent pain for at least 6 months at the
inferior pole of the patella;19 were physically active at least three
times a week prior to the tendinopathy episode; and were able to
read and provide written informed consent. We restricted par-
ticipation to patients who had been clinically diagnosed with
patellar tendinopathy, and tendinosis was verified via ultra-
sound or magnetic resonance imaging. We focused on the more
severely affected patella in athletes with bilateral patellar
tendinopathy. Participants with inflammatory conditions, a
history of previous knee surgery, or symptoms other than those
of patellar tendinopathy were excluded.
2.2. Instrument
The VISA-P scale was developed in Australia by the Victo-
rian Institute of Sport Assessment to quantify symptom severity
in athletes with patellar tendinopathy.5 This brief, self-
administered questionnaire consists of eight items; six are used
to evaluate pain levels or disability in daily activities and spe-
cific functional tests and two provide information regarding
ability to play sport. Response options for each item are pro-
vided on a numeric rating scale (from 0 to 10), with higher
scores indicating lower levels of pain or disability for all items
ARTICLE IN PRESS JSHS264_proof ■ 11 April 2016 ■ 2/7
Please cite this article in press as: Sergio Hernandez-Sanchez, et al., Confirmatory factor analysis of VISA-P scale and measurement invariance across sexes in athletes with patellar
tendinopathy, Journal of Sport and Health Science (2016), doi: 10.1016/j.jshs.2016.01.020
2 S. Hernandez-Sanchez et al.
other than 7 and 8, for which options have weighted scores.
Item 7 has four possible rating levels (0, 4, 7, and 10). Item 8 is
divided into three assumptions (A, B, and C), from which only
one is chosen according to the impact of pain on engagement in
sport; this holds greater weight in the final score range (0–30 on
a Likert scale). The maximum score possible is 100 points and
represents an asymptomatic athlete who can fully engage in
sports. The theoretical minimum is 0 point.
2.3. Procedure
Participants completed a questionnaire, which recorded
demographic and clinical data related to patellar tendinopathy,
and the VISA-P scale during the first visit to medical staff
members employed by the clinics and sports teams. Each
patient was fully informed of the confidentiality of their
responses and the voluntary nature of their participation.
Written informed consent was obtained from the participants
before data collection. Ethical approval for the study was
granted by the Ethics and Experimental Research Committee at
Miguel Hernandez University.
2.4. Statistics
The normality, or distribution, of the VISA-P scale item
scores was examined by obtaining univariate skewness and
kurtosis values. According to Finney and DiStefano,20 univari-
ate skewness of greater than 2 and kurtosis of greater than 7
indicate non-normal distribution. Moreover, Mardia’s normal-
ized multivariate kurtosis coefficient was calculated, whereby a
value greater than 3 indicates non-normal distribution.21 In
addition, Cronbach’s α was used to estimate the internal con-
sistency of the scale.
Subsequent to these analyses, CFA was performed to inves-
tigate the internal structure of VISA-P scale items in a Spanish
sample; the maximum likelihood estimation method was used
to evaluate the fit of two hypothesized models. The first was an
original 1-factor model used in clinical practice to determine
symptom severity via the VISA-P scale;5 this method was also
used by Korakakis et al.12 in their exploratory analysis. The
second was an alternative 2-factor model that has been consid-
ered in other exploratory studies, with a second dimension,
sport participation, containing items 7 and 8.11,12 MGCFA was
used to examine the equivalence (measurement invariance) of
theVISA-P scale across sexes. The present study adhered to the
sequence recommended in other invariance studies22,23 as
follows: (1) test the CFA model separately in each group, (2)
conduct the simultaneous test of equal form (form invariance),
(3) assess the equality of factor loadings, (4) assess the equality
of intercepts, (5) assess the equality of errors, (6) assess the
equality of factor variance, and (7) assess the equality of latent
means.
The extent of factorial invariance was determined using χ2
differences between two nested models, via a based likelihood
ratio test. A nonsignificant result indicates that there is no
difference in fit between the constrained and unconstrained
models. However, the χ2 test is fairly sensitive to sample size;
therefore, the adequacy of the fit of the model was evaluated
using the following fit indices:24,25 relative chi-squared (χ2/df),
the comparative fit index (CFI), the goodness-of-fit index
(GFI), standardized root mean square residual (SRMR), and
root mean square error of approximation (RMSEA) including
confidence interval. Further, when the CFI difference (ΔCFI)
was larger than 0.01, model misfit was identified.26 Conven-
tional guidelines suggest that a good fit is indicated with CFI
values between 0.90 and 0.95 and SRMR values of less than
0.08.27 RMSEA values of less than 0.06 indicate a good fit, and
those of 0.08 or more indicate a reasonable fit.28 The criterion
for acceptance of a model was a χ2/df ratio of less than 3;
however, this cutoff value varies across studies, ranging from
greater than 2 to less than 5.28,29 In all cases, results were
considered statistically significant when the probability value
was less than or equal to 0.01. Statistical analyses were per-
formed using EQS 6.1 (version 6.1; Structural Equation Mod-
eling Software, Encino, CA, USA) for CFA and MGCFA and
SPSS 17.0 (SPSS Inc., Chicago, IL, USA) for descriptive
statistics.
There are no absolute guidelines regarding the minimum
sample size required for CFA.30 Some authors have reported
sample sizes of approximately 100–150 or 10 participants per
questionnaire item.31 Nevertheless, a sample size of at least 200
participants has also been recommended, and a considerably
higher number of participants may be required for models
involving many variables, latent factors, or estimated
parameters.16 In this study, thresholds of at least 10 participants
per VISA-P scale item and no fewer than 100 overall were
applied for CFA, as suggested by Gorsuch.32
3. Results
3.1. Descriptive statistics
The sample population was predominantly male (59.4%); the
participants’ mean ages were 30.2 ± 8.2 years for men and
27.5 ± 7.8 years for women. The majority of the participants
(75.5%) were recruited from sports medicine clinics. Partici-
pants’ (n = 249) descriptive and clinical characteristics are shown
in Table 1. Cronbach’s α was 0.74 for all VISA-P scale items.
3.2. Multivariate normality and assumptions
Table 2 shows the range of values for univariate skewness
and kurtosis, as well as Mardia’s normalized multivariate kur-
tosis values. Univariate skewness and kurtosis values indicated
univariate normality. There was no evidence of multivariate
non-normality.
3.3. Confirmatory factor analysis
3.3.1. Evaluating 1- and 2-factor solutions
CFA was conducted to evaluate the fit of two hypothesized
models. The results obtained for these models are shown in
Table 3. The data indicated that the 1-factor model obtained a
relative fit, and the errors for items 7 and 8 were correlated (i.e.,
not independent). Therefore, an alternative 1-factor model that
allowed for correlation of the errors for items 7 and 8 was tested
(Fig. 1). The 1-model fit with errors correlated was adequate
with respect to the GFI and CFI statistics, which was also the
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case for the 2-factor model. The error, in terms of the RMSEA
statistic, was within the upper accepted limits. However, χ2
values for the model remained significant, suggesting some
degree of misfit.
This indicates that items 7 and 8 are closely interrelated (i.e.,
they share more with each other than they do with the remain-
ing six items), which suggests that the items may not all
measure the same construct. This could be the reason why the
1-factor model with correlation of the errors for items 7 and 8
fits equally as well as the 2-factor model. Nevertheless, a factor
with only two indicators appears weak, as it is generally
accepted that definition of a factor requires at least three
variables.31,33
Factor loadings for 1-factor model modified related to the
VISA-P scale scores for the total sample are shown in Table 4.
3.3.2. Measurement invariance across sexes
Subsequent to identification of the VISA-P scale model with
the best fit, and considering the parsimony model principle,
measurement invariance was assessed across sexes for the
1-factor adjusted model (with correlation of the errors for items
7 and 8), using the sequential strategy described by Meredith
and Teresi.23
One-factor theoretical model was assessed separately for
each level of the sex variable. Initial testing of the hypothesized
Table 1
Descriptive characteristics of the study population (n = 249).
Men
(n = 148, 59.4%)
Women
(n = 101, 40.6%)
Age (year)a 30.2 ± 8.2 27.5 ± 7.8
Height (cm)a 1.8 ± 0.1 1.7 ± 0.1
Weight (kg)a 80.0 ± 11.2 64.6 ± 9.4
Body mass index (kg/m2)a 23.9 ± 2.4 21.9 ± 1.8
Chronicity (month)a 19.3 ± 22.1 17.6 ± 14.6
VISA-P scale baseline (point)a 46.0 ± 17.3 46.5 ± 17.1
Disciplineb
Volleyball 29 (19.6) 18 (17.8)
Basketball 14 (9.5) 20 (19.8)
Athletics 30 (20.3) 23 (22.8)
Soccer 32 (21.6) 6 (5.9)
Other 43 (29.0) 34 (33.7)
Training volumea
Day/week 4.4 ± 1.3 4.1 ± 1.1
h/day 2.0 ± 0.9 1.8 ± 0.8
Side of injuryb
Right 85 (57.4) 61 (60.4)
Left 63 (42.6) 40 (39.6)
First episodeb
Yes 104 (70.3) 70 (69.3)
No 44 (29.7) 31 (30.7)
a Data are presented as mean ± SD.
b Data are presented as mean with range or frequency (%) in brackets.
Abbreviations: VISA-P scale = the Victorian Institute of Sport Assessment-
Patella Scale.
Table 2
Values for the normality tests of the Victorian Institute of Sport Assessment-
Patella (VISA-P) scale scores.
Total Men Women
Univariate
Skewness −0.26 to 0.53 −0.20 to 0.60 −0.39 to 0.49
Kurtosis −0.35 to −0.69 −1.26 to −0.60 −1.10 to −0.39
Multivariate kurtosis 2.74 −0.36 2.81
Table 3
Goodness-of-fit indices in the confirmatory factor analysis of the VISA-P scale
for all sample (n = 249).
1-factor 1-factor* 2-factor
χ2 157.38 67.94 67.94
df 20 19 19
p <0.01 <0.01 <0.01
χ2/df 7.86 3.57 3.57
CFI 0.80 0.93 0.93
GFI 0.87 0.94 0.94
RMSEA
(95%CI)
0.17 (0.14–0.19) 0.10 (0.08– 0.13) 0.10 (0.08–0.13)
SRMR 0.10 0.06 0.06
* 1-factor model with errors for items 7 and 8 correlated.
Abbreviations: VISA-P scale = the Victorian Institute of Sport Assessment-
Patella Scale; CFI = comparative fit index; GFI = goodness-of-fit index;
RMSEA = root mean square error of approximation; CI = confidence interval;
SRMR = standardized root mean square residual.
Fig. 1. The 1-factor model with errors of items 7 and 8 correlated (final model).
VISA-P scale = the Victorian Institute of Sport Assessment-Patella Scale.
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model for both men and women indicated a marginally good fit
to the data. A review of the Lagrange Multiplier (LM) test
results (i.e., indices of model misfit) revealed that the error
covariance between items 7 and 8 was markedly misspecified.
Given the obvious relationship between items 7 and 8, the
model was respecified and re-estimated with the error covari-
ance included. This reparametrization resulted in an improve-
ment in the fit of the model (Table 5). Factor loadings across
sexes are shown in Table 4.
Configural or factorial invariance analysis was conducted
across sexes to determine whether the factor structure of the
VISA-P scale was the same for both men and women.
A baseline model (M1) with no equality constraints across
sex subsamples was tested, revealing that the model fit the data
reasonably well, with a CFI value of almost 0.95, an SRMR
value of almost 0.07, and an RMSEA value of less than 0.10
(Table 6). Thereafter, all free factor loadings were constrained
to be equal across groups (M2). The fit of this model was also
reasonable. Therefore, the χ2 difference test (Δχ2) indicated a
nonsignificant difference between the model with factor load-
ings constrained and the modified baseline model (p > 0.01).
The factor loadings and intercepts were both constrained to be
equal across groups (M3). The Δχ2 test for M3 and M2 indi-
cated that the factor loadings and intercepts were equivalent
across groups (p > 0.01). The model with factor loadings, inter-
cept, and error variance constrained (M4) was fit to the data; the
Δχ2 test indicated a nonsignificant difference between this
model and M3. The models with factor variance (M5) and
factor means (M6) constrained were then fit to the data;
Table 4
Factor loadings for the latent variables of the Victorian Institute of Sport
Assessment-Patella Scale for all samples and across sexes.
Item Statement Loading
Total Men Women
1 For how long can you sit pain free? 0.47 0.50 0.43
2 Do you have pain walking downstairs
with normal gait cycle?
0.71 0.67 0.71
3 Do you have pain at the knee with
full active non-weight bearing knee
extension?
0.54 0.55 0.52
4 Do you have pain when doing a full
weight-bearing lunge?
0.73 0.68 0.76
5 Do you have problems squatting? 0.73 0.56 0.82
6 Do you have pain during or
immediately after doing 10 single leg
hops?
0.85 0.87 0.84
7 Are you currently undertaking sport
or other physical activity?
0.25 0.34 0.25
8 For how long can you manage being
train/physically active?
0.41 0.32 0.44
Table 5
Goodness-of-fit indices in the confirmatory factor analyses of the VISA-P scale across sexes.
CFA Men Women
1-factor 1-factor* 1-factor 1-factor*
χ2 85.54 37.63 68.42 31.93
n 101 101
df 20 19 20 19
χ2/df 3.43 1.78 3.42 1.66
p <0.01 0.01 <0.01 0.03
CFI 0.74 0.92 0.84 0.96
GFI 0.84 0.91 0.86 0.93
RMSEA (95%CI) 0.18 (0.14–0.22) 0.10 (0.05–0.15) 0.16 (0.12–0.20) 0.08 (0.02–0.13)
SRMR 0.11 0.07 0.10 0.06
* 1-factor model with errors for items 7 and 8 correlated.
Abbreviations: VISA-P scale = the Victorian Institute of Sport Assessment-Patella Scale; CFA = confirmatory factor analysis; CFI = comparative fit index;
GFI = goodness-of-fit index; RMSEA = root mean square error of approximation; CI = confidence interval; SRMR = standardized root mean square residual.
Table 6
Invariance constraints across sexes.
Invariance level Model χ2 df p CFI GFI RMSEA (90%CI) SRMR Δχ2 Δdf p ΔCFI
Configural M1: free model (baseline) with E7/E8
correlated
69.55 38 <0.01 0.94 0.92 0.091 (0.06–0.12) 0.07 NA NA
Metric M2: M1 with factor loadings
constrained
77.22 45 <0.01 0.94 0.91 0.087 (0.05–0.12) 0.09 7.67 7 0.36 <0.01
Scalar M3: M1 with factor loadings and
intercepts constrained
82.92 52 <0.01 0.94 0.91 0.085 (0.05–0.12) 0.08 5.70 7 0.58 <0.01
Equal error variances M4: M1 with factor loadings, intercept
and error variances constrained
99.77 60 <0.01 0.92 0.89 0.088 (0.06–0.12) 0.09 16.85 8 0.03 0.016
Equal factor variances M5: M4 with factor variances
invariance constrained
99.83 61 <0.01 0.93 0.89 0.086 (0.06–0.11) 0.09 0.06 1 0.81 <0.01
Equal latent means M6: M5 with factor means constrained 99.95 62 <0.01 0.93 0.89 0.084 (0.05–0.11) 0.09 0.12 1 0.73 <0.01
Abbreviations: CFI = comparative fit index; GFI = goodness-of-fit index; RMSEA = root mean square error of approximation; CI = confidence interval;
SRMR = standardized root mean square residual; ΔCFI = comparative fit index difference.
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nonsignificant differences between M4 and M5 and M5 and M6
were observed. All goodness-of-fit indices indicated that all of
the tested models that assumed different degrees of invariance
were acceptable. None of the factor loading differences
between sexes were statistically significant. Moreover, nonsig-
nificant differences in latent means between men and women
were observed. Therefore, formal and measurement invariance
across sex was evidenced for the VISA-P scale.
4. Discussion
The VISA-P scale is a condition-specific questionnaire that
is used as a one-dimensional tool.5 In clinical practice, the final
VISA-P scale is used to monitor clinical severity and the prog-
ress of symptoms in athletes with patellar tendinopathy34 and is
even used as a criterion for return to play sport.35 Results of
previous EFA7,9,11,12 of the VISA-P scale have not reached con-
sensus with respect to the dimensions underlying the severity of
symptoms quantified by the scale.
This study represents a first attempt to examine the factor
structure of the VISA-P scale using CFA, which is a multivari-
ate statistical method that contributes to robust determination of
the latent factors underlying clinical concepts.24
Our findings support the one-dimensional model of the
VISA-P scale. This result is congruent with that of a study
conducted by Korakakis et al.,12 in which a 1-factor solution
was obtained when participants with other knee injuries were
excluded from EFA. This single-factor solution explained a
very high proportion of the variance. As suggested by the
authors, the existence of different symptom/severity constructs
in the other knee injury group may have affected factorial
validity. For this reason, the current sample consisted solely of
athletes with patellar tendinopathy.
Some of the results about dimensionality study require atten-
tion. In the adjusted one-dimensional model, the factor loading
for item 7 appeared to indicate different behavior from that of
the other items. Korakakis et al.12 considered this possibility
when they forced a 2-factor solution in their exploratory analy-
sis. It appears that item 7 was the main indicator in the scale for
reporting “sports participation”. The conflicting CFA results for
this item may have occurred as a result of the scoring formula.
Four values (0, 4, 7, or 10) are used to rate item 7, and this could
affect the variability of the scores, in that the item is unable to
reflect variability in athletes’ responses or situations. Future
validity studies could focus on different ways to rate this item or
test various response formats to clarify this issue.
With respect to the choice of the resultant model with cor-
related errors in CFA, considering the statistical principle of
parsimony, when two models have similar fit indices, the model
with fewer free parameters is preferred.36 Therefore, the results
of this study support a single-factor model for theVISA-P scale
and suggest that it should be considered a one-dimensional
instrument. However, as the scale reports on pain and disability
as well as sports participation and the limitation thereof, it may
reflect the impact of patellar tendinopathy on athletes’ activity
(disability) more realistically. Given these results, it would be
interesting, as well as consistent with the International Classi-
fication of Functioning, Disability and Health (ICF), to explore
more indicators of sports participation6 and resubmit the scale
to new analyses. Some recently published PROMs, such as the
Lower Limb Functional Index, have already addressed this
aspect of participation.37
Previous research has reported sex differences in pain inten-
sity, tolerance, duration, and thresholds.17,18 In addition,
Knobloch et al.38 observed a gender-specific differential
response to 12 weeks of eccentric training in patients with
Achilles tendinopathy: VISA-Achilles scores revealed that,
relative to men, symptomatic women reported lower pain
reduction and less improvement. Taking these sex differences
and their potential influence on VISA-P scale pain item scores
into account, the second aim of the present study was to
examine measurement invariance in the model with the best fit.
According to Cheung and Rensvold,26 a difference of <0.01 in
CFI values indicates that the invariance hypothesis should not
be rejected, and definite differences exist when differences in
CFI values are >0.02. Considering this rule, manifest mean
levels, latent mean comparisons, and results indicating that
VISA-P scale items have the same meanings across sexes
suggest that comparison across sexes is meaningful. This is an
important finding, as differences in observed scores between
men and women may not be directly comparable without evi-
dence of measurement invariance across sexes.39
There is a possibility that the sex differences in pain reported
in the literature are less pronounced in athletes.40 The physical
effort, coping strategies, greater motivation, and increased pain
tolerance and thresholds inherent in athletes may contribute to
homogeneous behavior in men and women.41 Nevertheless,
VISA-P scales were not affected by sex in our study.
The following limitations should be considered when inter-
preting these results. We employed a convenience sample of
Spanish injured athletes, which may not have been representa-
tive of all athletes with patellar tendinopathy. It is unclear
whether these results could be generalized to other populations
in terms of ethnicity, sport discipline, or geographical area.
With a larger sample size, it would be interesting to examine the
factorial invariance of the VISA-P scale across ages (e.g., ado-
lescents, adults, and older adults) and severity subgroups (e.g.,
competitive and recreational athletes) to identify potential dif-
ferences in latent variables. In addition, the lack of assessment
of different subgroups according to clinical characteristics and
psychological and socio-demographic status is another poten-
tial limitation. Accordingly, such measurement of invariance
would be desirable to avoid misinterpretation of differences in
VISA-P scale between athletes from different countries and
cultures.
5. Conclusion
The results of the present study indicated that the original
1-factor model of the VISA-P scale showed relative fit in a
sample of Spanish athletes with chronic patellar tendinopathy.
However some data suggested that additional factors could
represent the underlying structure of the scale more accurately;
therefore, further research is required. In addition, the 1-factor
VISA-P scale structure with correlation of the errors for items
7 and 8 was invariant across sexes, which indicates that men and
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women share a uniform structure of symptom severity, and their
VISA-P scale can be compared while avoiding sex bias. Further
larger studies are required to examine the VISA-P scale and
other PRO measures with a single score concurrently.
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